✦ LIBER ✦

SUNITINIB AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA (MRCC): UPDATED RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS FROM A PHASE III RANDOMISED TRIAL

✍ Scribed by S. Oudard; R.J. Motzer; M.D. Michaelson; T.E. Hutson; P. Tomczak; R.M. Bukowski; O. Rixie; S. Negrier; S.T. Kim; I. Chen; R.A. Figlin

Book ID: 119619026
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 74 KB
Volume: 7
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(08)60696-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

4509 POSTER Sunitinib versus interferon

4509 POSTER Sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC): updated efficacy and safety results and further analysis of prognostic factors

✍ Motzer, R.J.; Michaelson, M.D.; Hutson, T.E.; Tomczak, P.; Bukowski, R.M.; Rixe, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 65 KB

7122 Phase II trial of continuous once-d

7122 Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma (mRCC): preliminary results

✍ Barrios, C.H.; Hernandez-Barajas, D.; Brown, M.P.; Lee, S.H.; Fein, L.; Liu, J.H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

4510 POSTER A phase 2 trial of sunitinib

4510 POSTER A phase 2 trial of sunitinib in bevacizumab-refractory metastatic renal cell carcinoma (mRCC): updated results and analysis of circulating biomarkers

✍ Hutson, T.E.; George, D.J.; Michaelson, M.D.; Rosenberg, J.E.; Bukowski, R.M.; S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Axitinib versus sorafenib as second-line

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

✍ Motzer, Robert J; Escudier, Bernard; Tomczak, Piotr; Hutson, Thomas E; Michaelso 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 316 KB

Phase 3 trial of everolimus for metastat

Phase 3 trial of everolimus for metastatic renal cell carcinoma : Final results and analysis of prognostic factors

✍ Robert J. Motzer; Bernard Escudier; Stephane Oudard; Thomas E. Hutson; Camillo P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

Phase II trial of continuous once-daily

Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma

✍ Carlos H. Barrios; David Hernandez-Barajas; Michael P. Brown; Se-Hoon Lee; Luis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 855 KB